Mark Rosenblum

Chief Financial Officer & EVP

Professional Overview
Mark Rosenblum is an accomplished finance executive with extensive experience in the pharmaceutical and healthcare industries. As the Chief Financial Officer and Executive Vice President at Salarius Pharmaceuticals, Inc., he leverages his expertise in strategic financial management, business development, and operational leadership to drive the company's growth and success.

Experience Summary

Current Role
In his current role as CFO and EVP at Salarius Pharmaceuticals, Mark is responsible for overseeing the company's financial strategy, planning, and reporting. He plays a pivotal role in securing funding, managing investor relations, and ensuring the company's financial stability and long-term sustainability. Under his leadership, Salarius has achieved significant milestones, including securing funding, expanding its pipeline, and advancing its clinical development programs.

Career Progression
Prior to joining Salarius, Mark held senior finance positions at several leading pharmaceutical and biotechnology companies. He served as the Chairman of the Board of Directors and Chief Executive Officer at ActiveCare, Inc., where he spearheaded strategic initiatives and operational enhancements. As the Managing Director of CFO Services and Business Development at Brio Financial Group, he provided strategic and financial advisory services to clients in the healthcare and life sciences sectors. Additionally, Mark held Chief Financial Officer roles at Urigen Pharmaceuticals, Inc., Advaxis, Inc., and HemoBioTech, Inc., where he played a crucial role in financial management, capital raising, and business development.

Academic Background
Mark holds a Bachelor's degree in Accounting from a reputable university, where he graduated with honors. His strong academic background and continuous professional development have equipped him with a comprehensive understanding of financial best practices and industry-specific knowledge.

Areas of Expertise

• Financial strategy and planning

• Operational and capital management

• Fundraising and investor relations

• Mergers, acquisitions, and strategic partnerships

• Business development and commercialization

• Regulatory compliance and risk management

Professional Impact
Throughout his career, Mark has demonstrated a track record of driving financial performance, optimizing operational efficiency, and spearheading strategic initiatives that have positively impacted the companies he has served. His ability to navigate complex financial and regulatory landscapes, combined with his deep industry knowledge, has positioned him as a trusted leader and advisor in the pharmaceutical and healthcare sectors.

Conclusion
With his extensive finance expertise, industry-specific knowledge, and proven leadership capabilities, Mark Rosenblum is well-equipped to continue driving Salarius Pharmaceuticals' growth and success as its Chief Financial Officer and Executive Vice President. His commitment to excellence and his track record of delivering tangible results make him a valuable asset to the organization and a respected professional in the industry.